Ampio Pharmaceuticals
(OTC) AMPE
Ampio Pharmaceuticals Financials at a Glance
Market Cap
$173,200
Revenue (TTM)
$245.00K
Net Income (TTM)
$8.63M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.15
Volume
2
Open
$0.15
Price
$0.15
Volume
2
Open
$0.15
Previous Close
$0.15
Daily Range
$0.15 - $0.15
52-Week Range
$0.00 - $0.29
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.15
Volume
2
Open
$0.15
Previous Close
$0.15
Daily Range
$0.15 - $0.15
52-Week Range
$0.00 - $0.29
AMPE News
5 of Last Week's Biggest Winners
AMPE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ampio Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Michael A. Martino, MBA
Website
www.ampiopharma.comHeadquarters
Englewood, CO 80112, US
AMPE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$173.20K
Shares Outstanding
1.14M
Volume
2
Short Interest
0.00%
Avg. Volume
1.39K
Financials (TTM)
Gross Profit
$250.00K
Operating Income
$9.52M
EBITDA
$8.38M
Operating Cash Flow
$8.56M
Capital Expenditure
$0.00
Free Cash Flow
$8.56M
Cash & ST Invst.
$4.09M
Total Debt
$274.00K
Ampio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$245.00K
N/A
Gross Profit
$245.00K
+166.4%
Gross Margin
100.00%
N/A
Market Cap
$173.20K
N/A
Market Cap/Employee
$28.87K
N/A
Employees
6
N/A
Net Income
$2.05M
+2.4%
EBITDA
$2.21M
+12.0%
Quarterly Fundamentals
Net Cash
$3.81M
-67.8%
Accounts Receivable
$920.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$274.00K
-48.2%
Return on Assets
-1.50%
N/A
Return on Invested Capital
-2.83%
N/A
Free Cash Flow
$2.31M
+46.2%
Operating Cash Flow
$2.31M
+46.2%